Company profile for CHEMO

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimi...
More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Chemo Barcelona, Gran Via Carlos III, 98 7th floor 08028 Barcelona
Telephone
Telephone
+34 93 330 62 12
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”
This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

Impressions: 5385

https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

Radio Compass
16 Dec 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
FDA’s first generic approvals slump 21% in 2024; Novartis’ top seller Entresto, cancer blockbuster Tasigna lead 2024 patent cliff
A watershed moment in the journey of a drug is when it transitions from being a patented, high‐priced innovator product to an affordable generic.Through an inaugural approval, or a “first generic”,  the US Food Drug Administration (FDA) permits a manufacturer to market a generic version of a brand‐name drug — a process that, when successful, grants 180 days of exclusivity to the generic sponsor. This exclusivity is especially valuable when the drug in question is a blockbuster.In FDA’s fiscal year 2024 (i.e. from October 1, 2023 to September 30, 2024), the number of first-time generic drug approvals decreased by 21.3 percent — from 89 in FY 2023 to 70 in FY 2024, the lowest in at least nine years.Lupin emerged as a frontrunner in first generics, increasing its approvals from three in FY 2023 to seven in FY 2024, Apotex and Zydus Lifesciences from four to six, and Dr. Reddy’s from two to four. In contrast, Teva, Amneal, and Sun Pharma experienced a decline.Overall, neurology led the way with 10 approvals, while immunology saw eight, including three approvals in dermatology. Oncology and cardiology/vascular disease saw six approvals each. Ophthalmology saw five while psychiatry, and infectious diseases each contributed four approvals. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Novartis’ top seller Entresto, blockbuster Tasigna among six key drugs hit by generic rivalsIn 2024, the tide turned sharply for Novartis as it lost exclusivity for six of its drugs. Among them was its blockbuster Entresto, that has generated US$ 29.2 billion in revenue so far, including US$ 7.8 billion in 2024.A combination of sacubitril and valsartan, Entresto has transformed heart failure management. Entresto was the primary driver of Novartis’ sales growth last year. It was also one of the 10 drugs selected by the Biden administration in 2023 for Medicare price negotiations. Novartis has been fighting a fierce legal battle to protect Entresto from generic competition. In 2024, Entresto’s generic saga reached a crescendo. Alembic Pharmaceuticals, Laurus Labs, and Crystal Pharmaceutical’s generic versions of Entresto received FDA approval in May last year. But the Swiss drugmaker has noted that as of January 2025, there were no Entresto generics available in the US.Novartis’ Tasigna (nilotinib) has been a cornerstone in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Apotex won approvals for generics of 50 mg, 150 mg, and 200 mg of nilotinib formulations, thereby offering a more affordable option for both adult and pediatric patients. Owing to the generics, Tasigna’s sales fell 10 percent in 2024.Novartis’ Mekinist (trametinib), Votrient (pazopanib), Rydapt (midostaurin), and Promacta (eltrombopag) have long been critical treatments in oncology and hematology. With generic competition hitting these key assets, Novartis is now aggressively forging deals to strengthen its pipeline. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  FDA clears first generics for Neurocrine’s Ingrezza, Supernus’s Gocovri, ALS drugsIn psychiatry, Neurocrine Biosciences’ Ingrezza (valbenazine) capsules have carved out a niche for themselves as a first-in-class treatment for tardive dyskinesia, a movement disorder that can develop as a side effect of long-term use of antipsychotic meds. Two generics for Ingrezza from India’s Zydus and Lupin bagged FDA approval, as Ingrezza sales topped US$ 2.3 billion last year.Zydus also won first generic approval for Supernus Pharmaceuticals’ Gocovri (amantadine) extended-release capsules, which is a treatment of dyskinesia in Parkinson’s disease patients receiving levodopa-based therapy.Four companies received FDA approvals for their first generics of Mitsubishi Tanabe’s patented drug Radicava (edaravone). These are Dr. Reddy’s Laboratories, Gland Pharma (a Fosun Pharmaceutical subsidiary), Hikma and Long Grove. Radicava is a drug that treats amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. Another treatment for ALS from Italfarmaco — Tiglutik (riluzole) — received a first generic when FDA okayed Alkem Laboratories riluzole oral suspension. The med helps slow disease progression. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Pfizer’s Ibrance, Gilead’s Descovy, Lilly’s Olumiant treatment come under generic pressureIn oncology, Synthon Pharmaceuticals launched its generic version of Pfizer’s Ibrance (palbociclib) tablets. Generating sales of US$ 4.4 billion in 2024, this groundbreaking CDK4/6 inhibitor is Pfizer’s best-selling cancer drug. It has transformed treatment for hormone receptor-positive, HER2-negative advanced breast cancer by halting cancer cell division and significantly extending progression-free survival when combined with endocrine therapy.Descovy, a combination of emtricitabine and tenofovir alafenamide, stands as one of the most important therapies in the fight against HIV infection and related conditions. Originally developed by Gilead Sciences, Descovy has played a pivotal role in modern antiretroviral therapy, contributing US$ 2.1 billion to Gilead’s revenue in 2024. Apotex’s first generic approval for Descovy marked its second copycat for a blockbuster drug in 2024. The other generic approval it got its hands on was for Boehringer Ingelheim’s Pradaxa (dabigatran etexilate), a blood thinner that posted sales of € 845 million (US$ 883 million) in 2023.In immunology, Eli Lilly’s Olumiant (baricitinib) has emerged as an important therapy for treating inflammatory conditions such as rheumatoid arthritis. Aurobindo Pharma bagged FDA approval for generic baricitinib tablets.Ipsen’s Somatuline Depot (lanreotide) injection, a treatment for neuroendocrine tumors and endocrine disorders that generated about € 1.07 billion (US$1.1 billion) in 2023 sales, also has a generic now, with Cipla’s subsidiary InvaGen Pharmaceuticals receiving an FDA approval. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available) FDA okays copycats for opioid withdrawal med Lucemyra, weight loss drug Qsymia, contraceptive SlyndFDA also demonstrated a focused commitment to addressing two of the nation’s biggest public health concerns — the opioid crisis and obesity. Lucemyra (lofexidine), originally developed by US WorldMeds, is a non-opioid medication indicated for mitigating symptoms associated with acute opioid withdrawal and facilitating the completion of opioid discontinuation treatment. The introduction of Indoco Remedies’ generic version is poised to expand access to this critical therapy by offering a cost-effective alternative for managing substance use disorders.Vivus’ Qsymia (phentermine/topiramate), a chronic weight management therapy, also received a first generic. Actavis’ generic for Qsymia provides a more accessible option to patients striving to lose weight. Actavis is a subsidiary of Teva.FDA also approved Lupin’s first generic version of Insud Pharma’s Slynd—a progestin‑only contraceptive containing 4 mg drospirenone for use by females of reproductive potential to prevent pregnancy. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Our viewOver the next two years, several blockbusters such as Novo Nordisk’s Ozempic (semaglutide), AstraZeneca’s Farxiga (dapagliflozin), Bristol Myers Squibb’s Revlimid (lenalidomide) and its Pfizer partnered drug Eliquis (apixaban) stand to lose their patent protection. We expect more patent litigations and some exciting innovations in the generics space.

Impressions: 626

https://www.pharmacompass.com/radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff

#PharmaFlow by PHARMACOMPASS
20 Feb 2025

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211783

FDA
10 Aug 2022

https://endpts.com/fda-shoots-down-petition-to-stall-generic-versions-of-bristol-myers-blockbuster-chemo-abraxane/

ENDPTS
07 Jul 2021

https://www.contractpharma.com/contents/view_breaking-news/2021-06-24/chemomab-and-agc-biologics-partner-to-manufacture-cm-101-for-phase-iiiii/?widget=listSection

CONTRACTPHARMA
24 Jun 2021

https://www.sciencedaily.com/releases/2021/04/210401112549.htm#:~:text=Those%20receiving%20the%20chemotherapy%20drug,difference%20of%20about%203%C2%BD%20months.

SCIENCEDAILY
01 Apr 2021

http://www.business-standard.com/article/companies/chemo-group-opens-plant-in-hyderabad-with-rs-100-cr-investment-117092701118_1.html

BUSINESS-STANDARD
27 Sep 2017

https://www.biospectrumasia.com/news/33/9403/u-s-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease.html

BIOSPECTRUM
31 Aug 2017

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact CHEMO and get a quotation

CHEMO is a supplier offers 180 products (APIs, Excipients or Intermediates).

Find a price of Perampanel bulk with DMF offered by CHEMO

Find a price of Abiraterone Acetate bulk offered by CHEMO

Find a price of Aciclovir bulk offered by CHEMO

Find a price of Aliskiren bulk offered by CHEMO

Find a price of Almotriptan Malate bulk offered by CHEMO

Find a price of Alprostadil bulk offered by CHEMO

Find a price of Altrenogest bulk offered by CHEMO

Find a price of Amorolfine Hydrochloride bulk offered by CHEMO

Find a price of Apremilast bulk offered by CHEMO

Find a price of Aripiprazole bulk offered by CHEMO

Find a price of Asenapine Maleate bulk offered by CHEMO

Find a price of Azithromycin bulk offered by CHEMO

Find a price of Barnidipine Hydrochloride bulk offered by CHEMO

Find a price of Beclomethasone Dipropionate bulk offered by CHEMO

Find a price of Belvig bulk offered by CHEMO

Find a price of Benazepril Hydrochloride bulk offered by CHEMO

Find a price of Benznidazole bulk offered by CHEMO

Find a price of Bimatoprost bulk offered by CHEMO

Find a price of Brexpiprazole bulk offered by CHEMO

Find a price of Brinzolamide bulk offered by CHEMO

Find a price of Budesonide bulk offered by CHEMO

Find a price of Bumetanide bulk offered by CHEMO

Find a price of Canagliflozin bulk offered by CHEMO

Find a price of Candesartan Cilexetil bulk offered by CHEMO

Find a price of Captopril bulk offered by CHEMO

Find a price of Cariprazine Hydrochloride bulk offered by CHEMO

Find a price of Celecoxib bulk offered by CHEMO

Find a price of Chloramphenicol Succinate Acid bulk offered by CHEMO

Find a price of Ciprofloxacin bulk offered by CHEMO

Find a price of Ciprofloxacin Hydrochloride bulk offered by CHEMO

Find a price of Clonixin Lysine bulk offered by CHEMO

Find a price of Cloprostenol Sodium bulk offered by CHEMO

Find a price of Cloxazolam bulk offered by CHEMO

Find a price of Dabigatran Etexilate Mesylate bulk offered by CHEMO

Find a price of Dapagliflozin bulk offered by CHEMO

Find a price of Dapoxetine Hydrochloride bulk offered by CHEMO

Find a price of Desogestrel bulk offered by CHEMO

Find a price of Dexlansoprazole bulk offered by CHEMO

Find a price of Dienogest bulk offered by CHEMO

Find a price of Dofetilide bulk offered by CHEMO

Find a price of Donepezil bulk offered by CHEMO

Find a price of Doxazosin Mesylate bulk offered by CHEMO

Find a price of Dronedarone Hydrochloride bulk offered by CHEMO

Find a price of Drospirenone bulk offered by CHEMO

Find a price of Droxidopa bulk offered by CHEMO

Find a price of Duloxetine Hydrochloride bulk offered by CHEMO

Find a price of Dydrogesterone bulk offered by CHEMO

Find a price of Edaravone bulk offered by CHEMO

Find a price of Efinaconazole bulk offered by CHEMO

Find a price of Eletriptan Hydrobromide bulk offered by CHEMO

Find a price of Eluxadoline bulk offered by CHEMO

Find a price of Empagliflozin bulk offered by CHEMO

Find a price of Enalapril Maleate bulk offered by CHEMO

Find a price of Eplerenone bulk offered by CHEMO

Find a price of Ertugliflozin bulk offered by CHEMO

Find a price of Esomeprazole Magnesium bulk offered by CHEMO

Find a price of Esomeprazole Sodium bulk offered by CHEMO

Find a price of Eszopiclone bulk offered by CHEMO

Find a price of Ethinyl Estradiol bulk offered by CHEMO

Find a price of Etonogestrel bulk offered by CHEMO

Find a price of Famotidine bulk offered by CHEMO

Find a price of Fampridine bulk offered by CHEMO

Find a price of Febuxostat bulk offered by CHEMO

Find a price of Fenoterol Hydrobromide bulk offered by CHEMO

Find a price of Fingolimod Hydrochloride bulk offered by CHEMO

Find a price of Flecainide bulk offered by CHEMO

Find a price of Fluconazole bulk offered by CHEMO

Find a price of Fluoxetine Hydrochloride bulk offered by CHEMO

Find a price of Fluticasone Furoate bulk offered by CHEMO

Find a price of Fluticasone Propionate bulk offered by CHEMO

Find a price of Formoterol Fumarate bulk offered by CHEMO

Find a price of Fulvestrant bulk offered by CHEMO

Find a price of Gestodene bulk offered by CHEMO

Find a price of Glimepiride bulk offered by CHEMO

Find a price of Glycopyrronium Bromide bulk offered by CHEMO

Find a price of Guanfacine bulk offered by CHEMO

Find a price of Ibandronate Sodium bulk offered by CHEMO

Find a price of Idebenone bulk offered by CHEMO

Find a price of Imatinib Mesylate bulk offered by CHEMO

Find a price of Indacaterol Maleate bulk offered by CHEMO

Find a price of Indapamide bulk offered by CHEMO

Find a price of Irbesartan bulk offered by CHEMO

Find a price of Isradipine bulk offered by CHEMO

Find a price of Itraconazole bulk offered by CHEMO

Find a price of Ivabradine Hydrochloride bulk offered by CHEMO

Find a price of Ivermectin bulk offered by CHEMO

Find a price of Ketoconazole bulk offered by CHEMO

Find a price of Ketorolac Trometamol bulk offered by CHEMO

Find a price of Lacosamide bulk offered by CHEMO

Find a price of Lansoprazole bulk offered by CHEMO

Find a price of Latanoprost bulk offered by CHEMO

Find a price of Lesinurad bulk offered by CHEMO

Find a price of Levofloxacin bulk offered by CHEMO

Find a price of Levomilnacipran bulk offered by CHEMO

Find a price of Levonorgestrel bulk offered by CHEMO

Find a price of Levonorgestrel Butyrate bulk offered by CHEMO

Find a price of Linagliptin bulk offered by CHEMO

Find a price of Linezolid bulk offered by CHEMO

Find a price of Loratadine bulk offered by CHEMO

Find a price of Losartan Potassium bulk offered by CHEMO

Find a price of Loteprednol Etabonate bulk offered by CHEMO

Find a price of Meloxicam bulk offered by CHEMO

Find a price of Memantine Hydrochloride bulk offered by CHEMO

Find a price of Miconazole Nitrate bulk offered by CHEMO

Find a price of Midodrine bulk offered by CHEMO

Find a price of Mirabegron bulk offered by CHEMO

Find a price of Mometasone Furoate bulk offered by CHEMO

Find a price of Moxifloxacin bulk offered by CHEMO

Find a price of Moxifloxacin Hydrochloride bulk offered by CHEMO

Find a price of Naratriptan Hydrochloride bulk offered by CHEMO

Find a price of Nedocromil Sodium bulk offered by CHEMO

Find a price of Netarsudil bulk offered by CHEMO

Find a price of Nintedanib Esylate bulk offered by CHEMO

Find a price of Nitazoxanide bulk offered by CHEMO

Find a price of Nomegestrol Acetate bulk offered by CHEMO

Find a price of Norgestimate bulk offered by CHEMO

Find a price of Obeticholic Acid bulk offered by CHEMO

Find a price of Ofloxacin bulk offered by CHEMO

Find a price of Olanzapine bulk offered by CHEMO

Find a price of Olodaterol Hydrochloride bulk offered by CHEMO

Find a price of Omeprazole bulk offered by CHEMO

Find a price of Omeprazole Magnesium bulk offered by CHEMO

Find a price of Omeprazole Sodium bulk offered by CHEMO

Find a price of Ozanimod Hydrochloride bulk offered by CHEMO

Find a price of Paliperidone bulk offered by CHEMO

Find a price of Paliperidone Palmitate bulk offered by CHEMO

Find a price of Pantoprazole Magnesium bulk offered by CHEMO

Find a price of Pantoprazole Sodium bulk offered by CHEMO

Find a price of Pentazocine bulk offered by CHEMO

Find a price of Perindopril Erbumine bulk offered by CHEMO

Find a price of Phentolamine Mesylate bulk offered by CHEMO

Find a price of Pirfenidone bulk offered by CHEMO

Find a price of Pitavastatin bulk offered by CHEMO

Find a price of Posaconazole bulk offered by CHEMO

Find a price of Pramipexole Dihydrochloride bulk offered by CHEMO

Find a price of Prasugrel Hydrochloride bulk offered by CHEMO

Find a price of Praziquantel bulk offered by CHEMO

Find a price of Pregabalin bulk offered by CHEMO

Find a price of Quetiapine Hemifumarate bulk offered by CHEMO

Find a price of Rabeprazole Sodium bulk offered by CHEMO

Find a price of Ramelteon bulk offered by CHEMO

Find a price of Ranitidine bulk offered by CHEMO

Find a price of Ranolazine bulk offered by CHEMO

Find a price of Rasagiline Mesylate bulk offered by CHEMO

Find a price of Rivaroxaban bulk offered by CHEMO

Find a price of Rizatriptan Benzoate bulk offered by CHEMO

Find a price of Roflumilast bulk offered by CHEMO

Find a price of Rosuvastatin Calcium bulk offered by CHEMO

Find a price of Sacubitril-Valsartan bulk offered by CHEMO

Find a price of Salmeterol Xinafoate bulk offered by CHEMO

Find a price of Selexipag bulk offered by CHEMO

Find a price of Sertraline Hydrochloride bulk offered by CHEMO

Find a price of Sibutramine Hydrochloride bulk offered by CHEMO

Find a price of Sildenafil Citrate bulk offered by CHEMO

Find a price of Sitagliptin Hydrochloride bulk offered by CHEMO

Find a price of Sitagliptin Phosphate bulk offered by CHEMO

Find a price of Sofosbuvir bulk offered by CHEMO

Find a price of Sulfamethylthiazole bulk offered by CHEMO

Find a price of Sumatriptan bulk offered by CHEMO

Find a price of Tafluprost bulk offered by CHEMO

Find a price of Tamsulosin bulk offered by CHEMO

Find a price of Tasimelteon bulk offered by CHEMO

Find a price of Telaprevir bulk offered by CHEMO

Find a price of Telmisartan bulk offered by CHEMO

Find a price of Terbinafine Hydrochloride bulk offered by CHEMO

Find a price of Terconazole bulk offered by CHEMO

Find a price of Tianeptine Sodium bulk offered by CHEMO

Find a price of Tibolone bulk offered by CHEMO

Find a price of Tiotropium Bromide bulk offered by CHEMO

Find a price of Travoprost bulk offered by CHEMO

Find a price of Trimegestone bulk offered by CHEMO

Find a price of Ulipristal Acetate bulk offered by CHEMO

Find a price of Valsartan bulk offered by CHEMO

Find a price of Venlafaxine Hydrochloride bulk offered by CHEMO

Find a price of Vilanterol Trifenatate bulk offered by CHEMO

Find a price of Vildagliptin bulk offered by CHEMO

Find a price of Zoledronic Acid bulk offered by CHEMO

Find a price of Zolmitriptan bulk offered by CHEMO

Find a price of Zolpidem Tartrate bulk offered by CHEMO

Find a price of Zopiclone bulk offered by CHEMO

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty